DESAI VEERAL (Chief Strategy & Dev. Officer) sold 43.0% of their position (197.29K shares) of AGILON HEALTH, INC. on the open market
Open‑market sale worth $4.03M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/18/2022ACC: 0001209191-22-020015
Officer· Chief Strategy & Dev. Officer
Since Apr 2021
-197.29K
Net shares
Net seller
$4.03M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
197.29K acquired · 394.58K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+197.29K
Price / share
$1.00
Trade value
$197.29K
% of position
75.3%
3/16/2022
261.96K→459.25K
Common Stock
Direct
Shares
−197.29K
Price / share
$20.41
Trade value
$4.03M
% of position
43.0%
3/16/2022
459.25K→261.96K
Total
Net shares
+0.00
Net value
-$3.83M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2022 | M · Option Exercise | +197.29K | $1.00 | $197.29K | 75.3% | 261.96K | 459.25K |
| Common Stock Direct | 3/16/2022 | S · Sale | −197.29K | $20.41 | $4.03M | 43.0% | 459.25K | 261.96K |
| Total | +0.00 | -$3.83M | ||||||
Derivative Transactions1
Options (Right to buy)
Direct
Converts to
Common Stock
197.29K shares
Shares
−197.29K
Strike price
1.00
Held after
899.60K
Exercisable
—
3/16/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Options (Right to buy) Direct | Common Stock197.29K shares | 3/16/2022 | M · Option Exercise | −197.29K | 1.00 | — | 899.60K |